Anti-PSMA (124)I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle

BACKGROUND: Prostate cancer (PCa) is the second leading cause of cancer-related death in the Western population. The use in oncology of positron emission tomography/computed tomography (PET/CT) with emerging radiopharmaceuticals promises accurate staging of primary disease, restaging of recurrent di...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Exp Clin Cancer Res
Main Authors: Frigerio, B., Morlino, S., Luison, E., Seregni, E., Lorenzoni, A., Satta, A., Valdagni, R., Bogni, A., Chiesa, C., Mira, M., Canevari, S., Alessi, A., Figini, M.
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2019
Fag:
Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6651934/
https://ncbi.nlm.nih.gov/pubmed/31337429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-019-1325-6
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker